Cellectis (CLLS) Invested Capital: 2014-2023
Historic Invested Capital for Cellectis (CLLS) over the last 9 years, with Sep 2023 value amounting to $81.2 million.
- Cellectis' Invested Capital rose 619.99% to $81.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $81.2 million, marking a year-over-year increase of 619.99%. This contributed to the annual value of $118.4 million for FY2022, which is 15.82% down from last year.
- Cellectis' Invested Capital amounted to $81.2 million in Q3 2023, which was up 414.29% from $15.8 million recorded in Q2 2023.
- In the past 5 years, Cellectis' Invested Capital ranged from a high of $463.9 million in Q4 2020 and a low of $6.1 million during Q1 2023.
- Moreover, its 3-year median value for Invested Capital was $203.7 million (2022), whereas its average is $157.6 million.
- Its Invested Capital has fluctuated over the past 5 years, first spiked by 920.72% in 2019, then crashed by 97.01% in 2023.
- Over the past 5 years, Cellectis' Invested Capital (Quarterly) stood at $95.0 million in 2019, then surged by 388.09% to $463.9 million in 2020, then declined by 18.90% to $376.2 million in 2021, then crashed by 35.29% to $243.4 million in 2022, then soared by 619.99% to $81.2 million in 2023.
- Its last three reported values are $81.2 million in Q3 2023, $15.8 million for Q2 2023, and $6.1 million during Q1 2023.